When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Zepbound Weight Loss Medication Approved by FDA to Treat ...

   www.aol.com/fda-approves-weight-loss-medication...

   The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

3. Lilly's weight-loss treatment Zepbound becomes first FDA ...

   www.aol.com/news/lillys-weight-loss-drug-zep...

   The FDA's approval is based on data from two trials involving 469 participants, in which Zepbound helped ease breathing difficulties in patients with moderate to severe obstructive sleep apnea.

4. FDA approves weight-loss drug Zepbound for obstructive ... - AOL

   www.aol.com/news/fda-approves-weight-loss-drug...

   The approval is the second indication for Zepbound, which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023.

5. FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet - AOL

   www.aol.com/lifestyle/fda-approves-zepbound-most...

   Zepbound, made by Eli Lilly, is the newest FDA-approved drug for weight loss. (It was previously a diabetes treatment known as Mounjaro.) FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet

6. US approves Lilly weight-loss drug, will compete with ... - AOL

   www.aol.com/news/us-fda-approves-lilly-weight...

   The FDA approved tirzepatide for weight loss under the brand name Zepbound. It has been available as Mounjaro for type 2 diabetes since 2022 and had increasingly been used "off-label" for weight ...

7. Woman opens up about losing 123 pounds with new weight loss ...

   www.aol.com/news/fda-approves-weight-loss-drug...

   On Nov. 8, the U.S. Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound, which, according to clinical trials, helped participants lose up to 52 pounds in 16 months.